1. Home
  2. STZ vs NTRA Comparison

STZ vs NTRA Comparison

Compare STZ & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellation Brands Inc.

STZ

Constellation Brands Inc.

HOLD

Current Price

$150.70

Market Cap

26.2B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$210.91

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STZ
NTRA
Founded
1945
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2B
28.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
STZ
NTRA
Price
$150.70
$210.91
Analyst Decision
Buy
Strong Buy
Analyst Count
19
14
Target Price
$172.63
$259.07
AVG Volume (30 Days)
1.7M
1.0M
Earning Date
04-08-2026
05-07-2026
Dividend Yield
2.65%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
$10,208,700,000.00
$210,939,000.00
Revenue This Year
N/A
$18.16
Revenue Next Year
$0.48
$20.00
P/E Ratio
$24.93
N/A
Revenue Growth
2.48
N/A
52 Week Low
$126.45
$131.81
52 Week High
$196.91
$256.36

Technical Indicators

Market Signals
Indicator
STZ
NTRA
Relative Strength Index (RSI) 46.56 56.90
Support Level $149.01 $194.03
Resistance Level $154.03 $220.65
Average True Range (ATR) 3.81 7.93
MACD 0.34 2.62
Stochastic Oscillator 32.17 76.69

Price Performance

Historical Comparison
STZ
NTRA

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: